Intravenous Ferric Carboxymaltose for Heart Failure With Iron Deficiency

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treatment of Iron Deficiency and Iron Deficiency Anemia With Intravenous Ferric Carboxymaltose in Pregnancy

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2018English

Pcv39 - Assessment of the Budget Impact of Intravenous Ferric Carboxymaltose (Fcm) for Treating Iron Deficiency Anemia in Congestive Heart Failure Patients in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Anaphylaxis to Intravenous Ferric Carboxymaltose

Journal of the Korean Neurological Association
2018English

Intravenous Ferric Carboxymaltose for Anaemia in Pregnancy

BMC Pregnancy and Childbirth
GynecologyObstetrics
2014English

Treatment of Iron Deficiency With or Without Anaemia With Intravenous Ferric Carboxymaltose in Gynaecological Practices – A Non-Interventional Study

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2014English

A Comment on the Comparative Safety of Intravenous Ferumoxytol Versus Ferric Carboxymaltose in Iron Deficiency Anemia

American Journal of Hematology
Hematology
2018English

Is an Additional Dose of Intravenous Ferric Carboxymaltose Useful in the Treatment of Iron Deficiency Anemia?

International Journal of Blood Research and Disorders
2019English

Intravenous Iron Treatment in Pregnancy: Comparison of High-Dose Ferric Carboxymaltose vs. Iron Sucrose

Journal of Perinatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
2012English

Safety and Efficacy of Ferric Carboxymaltose in Children and Adolescents With Iron Deficiency Anemia

Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy